Testosterone Treatment in Multiple Sclerosis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The structural brain correlates of cognitive deficits in adults with Klinefelter's syndrome.

  2006cited by this paper
• The role of aromatization in testosterone supplementation

  2005cited by this paper
• Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a

  2005cited by this paper
• Sex hormones modulate brain damage in multiple sclerosis: MRI evidence

  2005cited by this paper
• Natural history of multiple sclerosis.

  2005cited by this paper
• Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.

  2004cited by this paper
• Neuroprotective role of testosterone in the nervous system.

  2004cited by this paper
• Androgens and the ageing male.

  2004cited by this paper
• Testosterone amplifies excitotoxic damage of cultured oligodendrocytes

  2004cited by this paper
• Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report.

  2003cited by this paper
• ‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence

  2003cited by this paper
• A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease

  2003cited by this paper
• Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.

  2003cited by this paper
• Benefit of interferon &bgr;-1a on MSFC progression in secondary progressive MS

  2002cited by this paper
• Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis

  2002cited by this paper
• Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance.

  2002cited by this paper
• Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production1

  2001cited by this paper
• Testosterone supplementation improves spatial and verbal memory in healthy older men

  2001cited by this paper
• Neuroprotection by estradiol.

  2001cited by this paper
• Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.

  2001cited by this paper
• Neuropsychological effects of interferon β‐1a in relapsing multiple sclerosis

  2000cited by this paper
• Sex Steroids Modify Working Memory

  2000cited by this paper
• BrainSuite: An Automated Cortical Surface Identification Tool

  2000cited by this paper
• Brain morphology in Klinefelter syndrome

  2000cited by this paper
• Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells.

  1999cited by this paper
• Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors

  1999cited by this paper
• A Gender Gap in Autoimmunity

  1999cited by this paper
• Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.

  1997cited by this paper
• Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure

  1997cited by this paper
• A protective role for testosterone in adjuvant-induced arthritis.

  1995cited by this paper
• Androgen treatment prevents diabetes in nonobese diabetic mice

  1992cited by this paper
• The Increased Susceptibility of Women to Multiple Sclerosis

  1992cited by this paper
• Effect of castration and sex hormone treatment on survival, anti- nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice

  1978cited by this paper

• Impact of sex hormones on immune function and MS development

  2018cites this paper